Background
Fungal endocarditis, a rare but severe infection of the cardiac valves, is associated with significant morbidity and mortality. Recurrent aortic valve fungal endocarditis is an even rarer clinical entity with limited literature on management strategies. The condition is typically caused by the spread of fungal spores through the bloodstream, which can occur due to various factors, such as intravenous drug use, dental procedures, or intravascular or intracardiac medical devices. Symptoms of aortic valve fungal endocarditis may include fever, fatigue, shortness of breath, chest pain, and a new or changing heart murmur. Diagnosis typically involves a combination of blood tests, imaging studies, and cardiac catheterization.